An Educational Program

Inaugural West Coast Cardiovascular Forum: Current Insights and Future Directions



In Cooperation with:

 

Program Director: Valentin Fuster, MD, PhD, FACC

 

October 6-8, 2007
The Ritz Carlton
San Francisco, CA

 

PROGRAM PRESENTATIONS

Please note that pdfs are not listed for all program presentations as some faculty were unable to provide their full slide presentations to ACCF. Please refer to your printed syllabus for the key slides and/or abstracts that were released at the program.


Saturday, Oct. 6

5:00 p.m. Atherothrombosis: Cellular and Molecular Bases Mechanisms to Protect Vascular Health
Dr. Fuster

5:30 p.m. STEMI: Community Centers and New Aspects in Pharmacological Management
Dr. Antman

7:00 p.m. NSTE-ACS: Stratification for Selection of Patients for Intervention - New Aspects in Pharmacological Management
Dr. Roe

7:30 p.m. COURAGE and Stable Angina: A Case for Medical Management: Was the Interventional Management Biased by ACS Trials?
Dr. Boden

Sunday, Oct. 7

7:25 a.m. Welcome Remarks
Dr. Fung

7:30 a.m. IVUS: The Therapies for Atherosclerosis Victories and Failures
Dr. Nissen

7:55 a.m. From Risk Factors to Serum Markers
Dr. Wang

8:20 a.m. Carotid, Aortic and Peripheral Vascular Disease: Powerful Markers of Coronary Disease and Prognosis
Dr. Olin

9:50 a.m. Antithrombotics: Chronic Coronary Disease Stenting, Antiplatelet Resistance
Dr. Badimon

10:15 a.m. Lipid Modifying Agents: Are the Various Statins Different? HDL – Cholesterol, an Odd Molecule to Treat?
Dr. Shah

10:40 a.m. Recent Trials in Hypertension: Is There Anything Really New?
Dr. Frohlich

11:05 a.m. Diabetes: Are the Cardiologists Ready to Manage? If Not, Who is the Manager?
Dr. Farkouh

1:30 p.m. Cellular, Biochemical and Humoral Pathways: Helpful for the Clinician or for the Researcher?
Dr. Cohn

1:55 p.m. Hemodynamic Patterns: Relevant in Tailoring Therapy
Dr. Francis

2:20 p.m. How to Prevent Hospitalization: Home Quality Management
Dr. Yancy

3:35 p.m. From Risk Factors to Bioimaging Markers and Genetics
Dr. Fuster

4:00 p.m. Myocarditis, Biopsy and Immunotherapy
Dr. Francis

4:25 p.m. Defibrillator and/or Resynchronization Pacing
Dr. Conti

Monday, Oct. 8

7:30 a.m. Timing of Indications for Valvular Heart Surgery: Should We Advance the Clock?
Dr. Bonow

7:55 a.m. Approaches to the Dilated Thoracic Aorta: Should We Also Advance the Clock?
Dr. Elefteriades

8:20 a.m. Want Your Patient to Get a Valve Repair? Learn to Differentiate Mitral Valve Disease
Dr. Adams

8:45 a.m. New Aspects of Antithrombotic Therapy in Prosthetic Heart Valves and Co-morbidities
Dr. Fuster

10:00 a.m. Rate vs. Rhythm Control: Listen Carefully to the Patient, Project as His/Her Future, then the Algorithms
Dr. Conti

10:25 a.m. Antithrombotics for Stroke Prevention: What Guidelines to Follow
Dr. Fuster

10:50 a.m. Catheter Ablation as Compared to the Surgical Cox Maze: Myths and Realities
Dr. Conti

1:00 p.m. Cardiac Regeneration: Should We Return to the Basics?
Dr. Losordo

1:30 p.m. Genetics and Cardiomyopathy: Ready for the Clinics?
Dr. Ho

2:00 p.m. Multimodality Molecular Imaging: Ready For Humans
Dr. Fuster

2:30 p.m. Novelties on Percutaneous Aortic Valve Replacement: A Clinician’s Point of View
Dr. Fuster

3:00 p.m. From Treatment to the Protection of Cardiovascular Health: A Great Challenge of the 21st Century
Dr. Fuster

 

 

ADVERTISEMENT








Back to Top | | Copyright © 2008 American College of Cardiology
ACCInTouch Facebook Twitter LinkedIn
Heart House | 2400 N Street, NW | Washington, DC 20037